The Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus which infects at least 90% of the world's population". The virus infects B-Iymphocytes and certain epithelial cells, and plays an important role in the pathogenesis of certain B-cell lymphoproliferative diseases and nasopharyngeal carcinoma-,
In vitro EBV has the ability to immortalize uninfected B-cells into lymphoblastoid cell lines (LCLs) 3 . It was with one of these cell lines that Montagnier and his colleagues achieved successful replication of lymphadenopathy-associated virus (later re-named human immunodeficiency virus, HIV)4. This led Montagnier to speculate that EBV-transformed cells may have an important role in the pathogenesis of AIDS. However, the ubiquity of EBV infection in the general population would make it difficult to distinguish its involvement in the development of AIDS from its role as a persistent viral passenger; just as many of the clinical complications associated with EBV and other herpesviruses are not specific to HN infection, but to cell-mediated immune deficiency.
IMMUNOSUPPRESSION AND EUV INFECTION

Epithelial expression
Although much of our knowledge of EBVhas been established with in vitro studies of transformed LCLs, the virus persists in vivo in two cell types within the host; these are stratified oropharyngeal epithelium, which is probably the primary site of infections, and B-Iymphocytes 6 , During primary infection by the oral route, an initial focus of viral replication in epithelial cells ensures that EBV gains access to the lymphoid system by infecting B-cells passing through that area. Viral persistence in the oropharynx is reflected by shedding of EBV; at least 33% of healthy individuals shed significant levels of virus at anyone time", and as many as 50% of immunocompromized individualsf and 55% of HN-infected subjects do the same".
Increased epithelial EBV expression in HIV infection is manifested by the presence of oral hairy leukoplakia (OHL), which presents as raised, corrugated white areas on the lateral border of the tonguel". The histological appearance is characterized by very fine keratin projections, parakeratosis and koilocytosis of the prickle cell layer, Although the histology resembles a wart, papillomavirus has not been consistently demonstrated. Instead, the evidence points towards an explosive EBV infection, where active EBV replication is demonstrated by increased virus-encoded antigen expression and a large number of virus particles!', Since its initial description in HN infection, OHL has also been reported in other immunocompromized states, such as may occur in organ-transplant recipients on immunosuppressive therapy12,13, and in those with congenital T-cell deficiency (A J Pinching, personal communication). The common immunopathogenetic factor in OHL seems to be a depletion in, or functional disturbance of, epidermal populations of Langerhans' cells 14. These cells are dendritic, antigen-presenting CD4+ cells of bone-marrow origin which are responsible for eliciting T-cell responses towards locally-expressed foreign antigen. HIV has been observed to infect epithelial Langerhans' cells, leading to cytopathic changes'", suggesting that reduced local immunosurveillance is responsible for the uncontrolled replication of EBV.
Kitchen et al. have recently described lesions similar to OHL in the oropharynx and oesophagus of HIV-infected patients presenting with dysphagia". Unlike OHL, these oesophagealleukoplakias were deeply ulcerated, with rolled irregular edges. In situ hybridization with an EBV DNA probe demonstrated the virus within the lesions in 3 of the 4 cases. Herpes simplex virus and cytomegalovirus were not detected.
Additional evidence for a causal role for EBV is the regression of OHL and oesophageal leukoplakia with high doses of acyclovtrl? and ganciclovir (in the former)18, inhibitors of herpesvirus DNA polymerase. OHL regression with zidovudine has also been notedl", and this suggests some return of functional activity to Langerhans' cells. OHL provides a model for studying EBV expression in squamous epithelium. Recent work has focused on establishing OHL-epithelial cell Iines 20, and using immunofluorescence assays to study EBV Epstein-Barr virus is an important aetiological factor in certain HIV-related syndromes, with its opportunist expression related to the level of host immunodeficiency. In asymptomatic people coinfected with HIV, EBV activity is reflected by increased viral shedding and rises in anti-EBV titres; as immunodeficiency ensues EBV manifests as epithelial hyperproliferation in OHL, and later as B-cell lymphoma in AIDS. The suggested role of EBV as a co-factor in the progression of mv infection and development of AIDS has not been established, although another herpesvirus, cytomegalovirus, might play such a role 41 • Advances in our understanding of HIV regulation and its interaction with other latent (herpes)viruses should provide important molecular and pharmacological approaches to the clinical management of advanced mv disease.
SUMMARY
Having described some of the clinical scenarios in which EBV has been implicated, what direct effect does this herpesvirus have on mv infection and AIDS?In vitro studies on EBV-HIV interactions have demonstrated trans-activation of the long terminal repeat region (LTR) of HIV by EBVimmediate early gene products". The LTR is an important regulatory sequence of the HIV genome 32, and it is suggested that increased EBV replication, brought about by a decline in immune surveillance could, in turn, be responsible for stimulating HIV replication, leading to celllysis, infection of further susceptible cells with worsening immunodeficiency. However, the major argument against this hypothesis is that EBV and HIV do not share the same cell tropism in vivo. HIV preferentially infects CD4+ (helper) lymphocytesv and cells of the monocyte/macrophage lineage 34 , whereas EBV infects epithelial cells 35 and B-cells 36 bearing the receptor to the C3d component of complement (CD21). Exceptionally, EBV has been associated with rare T-celllymphomas 37 , 38 and has also been demonstrated in CD4+ lymJ'hocytes in particular clinical 39 and experimental circumstances, but not as yet in the context of HIV co-infection.
EBV INFECTION AND AIDS
Response to cytotoxic chemo-and radiotherapy has been disappointing, and is complicated by the direct toxicity of treatment and the frequent occurrence of opportunist and iatrogenic neutropenic infections resulting from poor bone marrow reserve'", Lymphoproliferative disease Once B-cells are infected by EBV, proliferation is kept in check by powerful immunological mechanisms; the best characterized of which are mediated by HLA class I-restricted virus-specific cytotoxic T-lymphocytes (CTLs) and natural killer cells 22 • EBV persistence in these B-cells stimulates a large number of CTLs in the circulation of healthy virus carriers, and it is believed that T-cell immune surveillance is continually restraining virus-induced lymphoproliferation.
Individuals with cellular immunodeficiency are at increased risk of B-cell lymphomas-t. These risks e exemplified in mvinfection, with a 40-60-fold mcrease in non-Hodgkin's lymphomas 24 • EBV has been implicated in the pathogenesis of some of these opportunist tumours, where EBV genomes or EBVassociated nuclear antigens are found in 25-50% of cases, depending on the method of detection used 25 ,26. Two clinicopathological groups of AIDSassociated lymphomas have been described. One group resembles EBV-related immunoblastic B-cell ymphomas that develop in individuals with primary unmunodeficiency and following organ transplantation, whilst the other group resembles Burkitt's ymphoma (BL)27. The feature common to all BLs IS the translocation of the c-myc proto-oncogene on chromosome 8 with one of the three immunological gene loci on chromosome 14 (heavy chain), chromosome '2 (kappa light chain) or chromosome 22 (lambda light chain). Thisrearrangement is thought to lead to a loss of control of expression of the C-myc proto-oncogene and is considered to be the c~mmon pathway of oncogenesis in BL. Subt~e differences occur between the BLsfound in endemic a~eas and the sporadic cases in AIDS. These differences are in the translocation breakpoint on chromosome 14 28 , as well as in the frequency of the Various rearrangements with chromosome 8. AIDSassociated BLs are also aetiologically distinct from the. endemic cases classically found in equatorial Africa, where early childhood infection with EBV an~living in areas holoendemic for Plasmodium fal~lparum malaria are important factors 29 • It will be of mterest to see if, in the geographical zones where the traditional'BL belt of Africa' overlaps with areas of high seroincidence for HIV, there is a trend away from the childhood predominance of endemic BL towards AIDS-associated BL in adults. However, this observation may be confounded by other f~ctors, such as the high mortality of infantile AIDS, disseminated tuberculosis and advanced Kaposi's sarc~ma affecting the overall presentation and Survival of AIDS cases in Africa. .Oinically, AIDS lymphomas are extra-lymphatic high-grade tumours, which commonly affect the central nervous system, but can also involve intra-2 abdOminal viscera, chest, heart and oral cavity. expression associated with epithelial differentiation, albeit in the context of immune suppression".
